ACCELERON PHARMA INC 3 SEC Filings

Filed On	Filing
17 Sep 2020	Form 3: Hamill Laura, Director No securities owned
06 Jul 2020	Form 3: Bristol Myers Squibb Co, 10% owner Holds 6,971,772 shares of Common Stock
05 Jun 2020	Form 3: Hite Christopher, Director No securities owned
03 Jan 2020	Form 3: Malik Kemal, Director No securities owned
17 Dec 2019	Form 3: Backstrom Jay T., EVP, Research and Development No securities owned
07 Jun 2019	Form 3: Veness Adam M, VP, General Counsel and Sec. Holds 19,631 shares of Common Stock
05 Jul 2018	Form 3: Zeldin Robert K, EVP & Chief Medical Officer No securities owned
13 Feb 2018	Form 3: Kango Sujay, SVP, Chief Commercial Officer No securities owned
15 Nov 2017	Form 3: Smith Karen L., Director No securities owned
08 May 2017	Form 3: Rovaldi Christopher, SVP, Program Mgmt and Ops Holds 40,967 shares of Common Stock
05 Dec 2016	Form 3: Dable Habib J, Director No securities owned
25 Jul 2016	Form 3: Mccourt Thomas A, Director No securities owned
12 Dec 2014	Form 3: Nader Francois, Director No securities owned
16 Jul 2014	Form 3: Kearney Terrence C, Director No securities owned
19 Sep 2013	Form 3: Atv Entrepreneurs VII, L.p., 10% owner Holds 9,732 shares of Common Stock
18 Sep 2013	Form 3: Advanced Technology Ventures VI, L.p., 10% owner and 7 others Holds 9,732 shares of Common Stock
18 Sep 2013	Form 3: Orbimed Advisors Llc, 10% owner and 2 others Holds 5,825 shares of Common Stock
18 Sep 2013	Form 3: Venrock Associates Iv L P, 10% owner and 5 others Holds 9,732 shares of Common Stock
18 Sep 2013	Form 3: Evnin Anthony B, Director Holds 9,732 shares of Common Stock
18 Sep 2013	Form 3: Steininger Robert J Ii, SVP, Manufacturing

Comments